Human Fibrinogen Concentrates Market Revenue to Attain USD 2.33 Bn by 2033

28 Oct 2025

Share :

Table of Content

1. Human Fibrinogen Concentrates Market Revenue and Trends 2025 to 2033 2. What are the Major Factors Driving the Growth of the Market? 3. Segment Insights 4. Regional Insights 5. Human Fibrinogen Concentrates Market Coverage

Human Fibrinogen Concentrates Market Revenue and Trends 2025 to 2033

The global human fibrinogen concentrates market revenue reached USD 1.33 billion in 2025 and is predicted to attain around USD 2.33 billion by 2033 with a CAGR of 7.26%. The market is growing because of the increasing incidence of bleeding disorders, growing volumes of surgical and trauma procedures, and evolving regulatory approvals.

What are the Major Factors Driving the Growth of the Market?

The human fibrinogen concentrates market is driven by several key factors. The rising prevalence of both congenital and acquired fibrinogen deficiencies is driving demand for safer, more standardized replacement therapies, especially in high-risk surgical scenarios. The shift from cryoprecipitate to fibrinogen concentrates is gaining momentum due to the advantages of precise dosing, reduced risk of viral transmission, faster reconstitution, and improved logistical efficiency in emergency care. Advances in biotechnology and increased R&D investments are leading to the development of improved formulations, enhancing stability, safety, and efficacy, thus broadening market reach.

Growing awareness and endorsement of clinical practice guidelines among healthcare professionals regarding the early and frequent use of fibrinogen in bleeding protocols are also contributing to market growth. Finally, the expansion of healthcare systems in developing economies, coupled with favorable reimbursement policies and increased healthcare spending, is expected to further support global market expansion.

Segment Insights

• By type, the plasma-derived fibrinogen concentrates segment dominated the market in 2024, due to established, clinically approved supply chains and widespread clinician familiarity with plasma-based therapies.
• By application, the congenital fibrinogen deficiency segment led the market in 2024, driven by the need for life-long treatment and prophylaxis, which results in consistent demand and higher per-patient dosing.
• By end-user, the hospitals segment dominated the market in 2024, owing to the high volume of surgical procedures, the ability to manage trauma cases, and the acute care environment where fibrinogen is frequently required on demand.
• By distribution channel, the hospital pharmacies segment held the largest market share in 2024, as they are deeply integrated into hospital supply chains and play a key role in managing critical care inventory.

Regional Insights

North America dominated the human fibrinogen concentrates market with the largest share in 2024 due to substantial healthcare funding, well-established clinical practice guidelines, and the early adoption of fibrinogen therapy in both trauma and surgical settings. The U.S. significantly contributes to this demand, driven by high volumes of trauma, cardiac, and orthopedic surgeries. The region's well-established healthcare sector and regulatory frameworks further support its dominance.

Asia Pacific is experiencing the most rapid growth, fueled by expanding medical infrastructure, rising surgical volumes, increased blood plasma collection capacity, and growing awareness in markets like China, India, and Southeast Asia. Local entities are investing in plasma fractionation facilities and partnering with global biopharma companies to reduce import reliance and accelerate access to treatments.

Human Fibrinogen Concentrates Market Coverage

Recent Development

• In June 2025, Grifols revealed that its fibrinogen therapy BT524 is slated for European launch in 2025, with U.S. approval expected by early 2026, following favorable Phase III trial results (AdFIrst study) published in eClinicalMedicine.  (Source: https://druganddeviceworld.com)

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/7029

You can place an order or ask any questions, please feel free to contact us at sales@precedenceresearch.com |+1 804 441 9344